SynthesisWorld journal of urology2020
Efficacy and safety of aquablation of the prostate for patients with symptomatic benign prostatic enlargement: a systematic review.
Synthesis in World journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 16 citations in OpenAlex.
- [One-year randomized controlled trial outcomes after aquablation and transurthral resection of the prostate for the treatment of lower urinary tract symptoms].Der Urologe. Ausg. A · 2020Trial
- Quality-of-life outcomes following Aquablation in men with poor initial quality of life: pooled analysis of five international studies.Prostate international · 2026Article
- Editorial Comments to "Optimizing Patient Selection for Aquablation During the Initial Adoption Phase: Prostates Smaller Than 100 mL".International journal of urology : official journal of the Japanese Urological Association · 2026Article
- Aquablation for benign prostatic hyperplasia: real-world prostate size relevance and bleeding events across 6 years.BJU international · 2026Article
- Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database.BJUI compass · 2026Article
- A Narrative Review of Robotic Aquablation in Benign Prostatic Hyperplasia Care: Where We Are Now.Cureus · 2025Review
- Aquablation, a safe technique?Central European journal of urology · 2025Article
- Aquablation in men with benign prostate hyperplasia: A systematic review and meta-analysis.Current urology · 2023Article
- Surgical Complications in the Management of Benign Prostatic Hyperplasia Treatment.Current urology reports · 2022Review
- Evolution of AquablationVR-From innovation to establishment.Turkish journal of urology · 2021Article
- Reasons to overthrow TURP: bring on Aquablation.World journal of urology · 2021Review
- Aquablation for benign prostatic obstruction: Single center technique evolution and experience.Investigative and clinical urology · 2021Article
- Current Treatment for Benign Prostatic Hyperplasia.Deutsches Arzteblatt international · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of this systematic review is to summarize the contemporary literature on aquablation and evaluate its safety and efficacy for the treatment of symptomatic BPE. EVIDENCE ACQUISITION: A systematic search of English language literature was performed using the PubMed-MEDLINE and Web of Science libraries up to 24 July 2019 by combining PICO (patient population, intervention, comparison, and outcome) terms. We retrieved 16 studies, including 446 patients treated with aquablation eligible for data extraction and analysis. Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines were followed. EVIDENCE SYNTHESIS: We identified a randomized controlled trial (RCT) comparing aquablation to transurethral resection of the prostate (TURP) with 6-month, 1-year, and 2-year outcomes, three single-center and single-arm studies, three multicenter and single-arm studies, and five subgroup analyses. Aquablation significantly improved International Prostate Symptom Score (IPSS), IPSS-quality of life (IPSS-QoL), maximum urinary flow rate (Q
conclusionsData from the WATER trial demonstrates that aquablation is comparable to TURP in effectively improving symptom scores and functional parameters related to BPE and bladder outlet obstruction. The evidence provided supports the safety of aquablation assessed by procedure-related adverse events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.